about
Flavaglines alleviate doxorubicin cardiotoxicity: implication of Hsp27Keeping abreast with long non-coding RNAs in mammary gland development and breast cancerNatural compounds in the human diet and their ability to bind mutagens prevents DNA-mutagen intercalationComparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouseChemotherapy-Induced Cardiotoxicity: Pathophysiology and PreventionAnthracycline cardiotoxicity: from bench to bedside.Doxorubicin pathways: pharmacodynamics and adverse effects.Anticancer activity expressed by a library of 2,9-diazaperopyrenium dications.Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.Cancer cell response to anthracyclines effects: mysteries of the hidden proteins associated with these drugsDavid and Goliath: chemical perturbation of eukaryotes by bacteria.Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients.Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression.Cellular glycosylation affects Herceptin binding and sensitivity of breast cancer cells to doxorubicin and growth factors.Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.Pixantrone: merging safety with efficacy.Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines.Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance.Proteomic analysis of the vitamin C effect on the doxorubicin cytotoxicity in the MCF-7 breast cancer cell line.Nuclear accumulation of anthracyclines in the endothelium studied by bimodal imaging: fluorescence and Raman microscopy.Biodegradable Poly(ester-urethane) Carriers Exhibiting Controlled Release of Epirubicin.Antibody-drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment.Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.Induction of cell death by a novel naphthoquinone containing a modified anthracycline ring system.Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathwaysThe anthracyclines: when good things go bad.Flexible synthesis of anthracycline aglycone mimics via domino carbopalladation reactions.Neferine ameliorates cardiomyoblast apoptosis induced by doxorubicin: possible role in modulating NADPH oxidase/ROS-mediated NFκB redox signaling cascade.Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative.Doxorubicin Induces Inflammatory Modulation and Metabolic Dysregulation in Diabetic Skeletal Muscle.Protective effect of Co-enzyme Q10 On doxorubicin-induced cardiomyopathy of rat hearts.Naphthoquinones: A continuing source for discovery of therapeutic antineoplastic agents.Conventional and high-dose daunorubicin and idarubicin in acute myeloid leukaemia remission induction treatment: a mixed treatment comparison meta-analysis of 7258 patients.Alpha lipoic acid prevents doxorubicin-induced nephrotoxicity by mitigation of oxidative stress, inflammation, and apoptosis in rats.Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment.Protective Effects of ω-3 PUFA in Anthracycline-Induced Cardiotoxicity: A Critical Review.Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines.Synthesis and in vitro antitumour activities of lupeol derivatives.Effects of the Combination of Gliotoxin and Adriamycin on the Adriamycin-Resistant Non-Small-Cell Lung Cancer A549 Cell Line.Protective effect of berberine on acute cardiomyopathy associated with doxorubicin treatment.
P2860
Q21135010-AFB9E650-549D-40FA-8B69-E29991EFB8BDQ26849813-7F3773F0-5177-4248-BC21-428E60490DB1Q28290373-9E6D63A5-6C62-42C1-96CA-E9B10A25E5C9Q28487998-FCD74C1A-1CF2-449A-AFAB-C26F88FF48FEQ30399577-3B0146B7-0F7F-4C3E-84E5-357FD4C6BE88Q34477415-EB950E3E-1B4B-4DE6-9993-50914773F6B2Q35048393-A7593154-48D5-4276-B649-1E688C44CEF6Q35130142-8BF79F90-DF99-4CE4-989E-564063619472Q36372894-E5E5DE23-6D22-43F8-B582-004A7C89BC60Q36538243-F3EF21A7-CD88-4788-A224-C88C07B4FD55Q36577080-4CE86DD5-3966-42B9-B26B-FE18FC983102Q36948123-BE5AC19A-A14E-49D3-9D22-37D8063698E9Q37230670-92FB4CAB-9753-4A61-A257-59AAAA277CF7Q37657607-FCA83926-9EBD-4365-9C83-51CD41BCC0CCQ37763152-97C2EECA-D5D0-4DD7-9E33-8D912B934951Q38078425-37E211CF-3B17-4A60-9E09-27C25DC9C199Q38576762-007B1DFC-2F5B-4883-B61A-84079CAFE774Q38737388-DB4D7937-7BCA-40E4-ABF1-D46E63FBDB06Q38746649-55570838-F680-4326-90CB-3E77FADF03DBQ38918849-83D2BF11-EA12-49FA-B6C8-017F7628C232Q39000865-38FCC1D5-B8FF-4365-BFD2-5803C7AAD204Q39030222-B3C5E609-37C1-424E-A84E-2399C6846514Q39268019-B8FDD1C4-6F80-4593-8F74-296B7F19CCBEQ39491036-DD922D02-A48B-44F6-8404-6C5AC72FDC61Q40954179-F097A976-B34B-4898-9C0B-9ED2BC12B0B2Q42163160-E5D6927E-BB0D-4DEC-B282-207BA5CFA42AQ42173292-D024E92C-8565-4DDF-914A-8E0BA6BA9693Q42363693-E30D9E04-2EC7-4321-802F-164A6513DC89Q42366841-E04F973B-93AB-4754-9305-58B6BA77A496Q42402464-5E471733-3D8B-41F3-9DBE-D975DFD073DDQ42698011-18445FDA-5CC5-4FFF-9824-A71D7C142283Q46262914-F50458EF-FD6F-4AC0-9B2C-1FC39972BBFEQ46702316-8B8C8142-65EC-427E-BD02-F418DFCC57B3Q46793487-A7C12D34-D886-4896-8A9A-77C6734231D1Q47726614-135EACC7-3114-4661-9847-9F2AF73481F7Q47787078-812D2B6C-04DA-453D-879C-4C501875C0F7Q48373900-693A71AB-EA83-4C08-BF38-44298F7F7AA1Q50872392-E57A855F-41BF-40D5-ACF5-3FB22624FAC8Q52690261-7D6E647C-63F6-4EAF-9BDD-5103B38026B7Q54982018-C671ED93-E634-448B-8998-4263F5ADB4BF
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Role of anthracyclines in the era of targeted therapy.
@en
type
label
Role of anthracyclines in the era of targeted therapy.
@en
prefLabel
Role of anthracyclines in the era of targeted therapy.
@en
P2860
P1476
Role of anthracyclines in the era of targeted therapy.
@en
P2093
Cyntia Coronado
Hernán Cortés-Funes
P2860
P2888
P356
10.1007/S12012-007-0015-3
P577
2007-01-01T00:00:00Z